Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies

COVID-19 (SARS-CoV-2) disease severity and stages varies from asymptomatic, mild flu-like symptoms, moderate, severe, critical, and chronic disease. COVID-19 disease progression include lymphopenia, elevated proinflammatory cytokines and chemokines, accumulation of macrophages and neutrophils in lun...

Descripción completa

Detalles Bibliográficos
Autor principal: Ricke, Darrell O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943455/
https://www.ncbi.nlm.nih.gov/pubmed/33717193
http://dx.doi.org/10.3389/fimmu.2021.640093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943455/
https://www.ncbi.nlm.nih.gov/pubmed/33717193
http://dx.doi.org/10.3389/fimmu.2021.640093

Ejemplares similares